NCT00319748 arm group d7c62c656fefeb3ba831b504e8fed085 [clinicaltrials_resource:NCT00319748/arm-group/d7c62c656fefeb3ba831b504e8fed085]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00319748 arm group d7c62c656fefeb3ba831b504e8fed085 [clinicaltrials_resource:NCT00319748/arm-group/d7c62c656fefeb3ba831b504e8fed085]
Bio2RDF identifier
NCT00319748/arm-group/d7c62c656fefeb3ba831b504e8fed085
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c62c656fefeb3ba831b504e8fed085
description [clinicaltrials_vocabulary:description]
Patients who received all 24 doses of 852A per protocol.
identifier
clinicaltrials_resource:NCT00319748/arm-group/d7c62c656fefeb3ba831b504e8fed085
title
NCT00319748 arm group d7c62c656fefeb3ba831b504e8fed085
@en
type
label
NCT00319748 arm group d7c62c65 ...... 62c656fefeb3ba831b504e8fed085]
@en